Drug:
Reaction: DERMATITIS ATOPIC
20260101 - 20261231
No. 1301 - 1400
| No. | safetyreportid |
occurcountry |
patientonsetage |
patientsex 1:M 2:F |
|---|---|---|---|---|
Adverse reaction |
||||
Drug (openfda.generic_name, medicinalproduct) |
||||
| 1301 | 26793186 |
US |
36 | 2 |
Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 1302 | 26793210 |
US |
2 | |
Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 1303 | 26793212 |
US |
54 | 2 |
Dermatitis atopic, Rash, |
||||
DUPILUMAB, |
||||
| 1304 | 26793220 |
US |
3 | 2 |
Sleep disorder due to a general medical condition, Dermatitis atopic, Rash, Discomfort, |
||||
DUPILUMAB, |
||||
| 1305 | 26793245 |
US |
2 | |
Dermatitis atopic, Therapeutic response shortened, Inappropriate schedule of product administration, |
||||
DUPILUMAB, |
||||
| 1306 | 26793274 |
US |
||
Rash, Pruritus, Dermatitis atopic, |
||||
NEMOLIZUMAB-ILTO, NEMOLIZUMAB-ILTO, |
||||
| 1307 | 26793287 |
US |
63 | 2 |
Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 1308 | 26793292 |
US |
15 | 2 |
Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 1309 | 26793309 |
US |
61 | 2 |
Alopecia, Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 1310 | 26793337 |
US |
41 | 1 |
Dermatitis atopic, Product dose omission issue, |
||||
DUPILUMAB, |
||||
| 1311 | 26793338 |
US |
56 | 1 |
Dermatitis atopic, Skin exfoliation, Skin haemorrhage, Pruritus, Therapeutic response decreased, |
||||
DUPILUMAB, ABROCITINIB, |
||||
| 1312 | 26793360 |
US |
2 | |
Blister, Injection site pain, Dermatitis atopic, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 1313 | 26793366 |
US |
41 | 1 |
Dermatitis atopic, Product dose omission issue, |
||||
DUPILUMAB, |
||||
| 1314 | 26793372 |
US |
1 | |
Dermatitis atopic, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 1315 | 26793394 |
US |
66 | 2 |
Dermatitis atopic, |
||||
DUPILUMAB, ETANERCEPT, |
||||
| 1316 | 26793463 |
US |
62 | 2 |
Dermatitis atopic, |
||||
DUPILUMAB, NEMOLIZUMAB-ILTO, |
||||
| 1317 | 26793465 |
US |
56 | 2 |
Dermatitis atopic, Pruritus, |
||||
DUPILUMAB, |
||||
| 1318 | 26793708 |
US |
1 | |
Therapy non-responder, Dermatitis atopic, |
||||
LEBRIKIZUMAB-LBKZ, |
||||
| 1319 | 26791965 |
US |
2 | |
Dermatitis atopic, |
||||
DUPILUMAB, ISOTRETINOIN, |
||||
| 1320 | 26792011 |
US |
2 | |
Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 1321 | 26792039 |
US |
68 | 2 |
Dermatitis atopic, Product dose omission issue, |
||||
DUPILUMAB, |
||||
| 1322 | 26792050 |
US |
72 | 2 |
Dermatitis atopic, Injection site pain, Incorrect dose administered, |
||||
DUPILUMAB, CALCIUM, CITALOPRAM, PANCRELIPASE, CYCLOBENZAPRINE HYDROCHLORIDE, CYCLOBENZAPRINE, ERGOCALCIFEROL, ESTRADIOL, ESTRADIOL GEL 0.1%, ESTRADIOL TRANSDERMAL, ESTRADIOL,, FLUTICASONE PROPIONATE, LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE, PROPRANOLOL HYDROCHLORIDE, MAGNESIUM, MINOXIDIL, MINOXIDIL FOAM 5% (WOMENS), CETIRIZINE HYDROCHLORIDE, |
||||
| 1323 | 26792053 |
US |
5 | 2 |
Dermatitis atopic, Product dose omission issue, Injection site pain, |
||||
DUPILUMAB, TACROLIMUS, TACROLIMUS OINTMENT 0.1%, TACROLIMUS EXTENDED-RELEASE CAPSULES, TRIAMCINOLONE ACETONIDE, TRIAMCINOLONE ACETONIDE OINTMENT USP, 0.05%, |
||||
| 1324 | 26792082 |
US |
1 | |
Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 1325 | 26792099 |
US |
53 | 2 |
Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 1326 | 26792159 |
US |
2 | |
Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 1327 | 26792160 |
US |
26 | 1 |
Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 1328 | 26792169 |
US |
1 | 1 |
Sensitivity to weather change, Dermatitis atopic, Product use in unapproved indication, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 1329 | 26792214 |
US |
5 | 1 |
Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 1330 | 26792410 |
US |
71 | 2 |
Dermatitis atopic, Rash, |
||||
DUPILUMAB, DUPILUMAB, ERGOCALCIFEROL, VENLAFAXINE HYDROCHLORIDE, NEMOLIZUMAB-ILTO, MORPHINE SULFATE, MAGNESIUM, CETIRIZINE HCL, CETIRIZINE, VENLAFAXINE HYDROCHLORIDE, |
||||
| 1331 | 26792429 |
US |
38 | 2 |
Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 1332 | 26792434 |
US |
43 | 1 |
Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 1333 | 26792474 |
CA |
72 | 2 |
Chest discomfort, Erythema, Pruritus, Depressed mood, Peripheral swelling, Secretion discharge, Sinusitis, Malaise, Cellulitis, Asthenia, Dermatitis atopic, Lower respiratory tract infection, Gastroenteritis viral, Back pain, Off label use, Gastrointestinal pain, Urticaria, Blister, Fatigue, Dyspnoea, Scab, Chills, Skin lesion, Cough, Neurodermatitis, COVID-19, Skin weeping, Pain of skin, Chest pain, |
||||
DONEPEZIL HYDROCHLORIDE, DUPILUMAB, DUPILUMAB, DUPILUMAB, DUPILUMAB, DUPILUMAB, DIMENHYDRINATE, ZINC, ZINC GLUCONATE, ZINC CHLORIDE, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, |
||||
| 1334 | 26792479 |
US |
2 | |
Dermatitis atopic, Therapeutic response shortened, |
||||
DUPILUMAB, |
||||
| 1335 | 26792486 |
US |
58 | 2 |
Urticaria, Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 1336 | 26792490 |
US |
10 | 2 |
Dermatitis atopic, Inappropriate schedule of product administration, |
||||
DUPILUMAB, |
||||
| 1337 | 26792564 |
US |
48 | 1 |
Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 1338 | 26792567 |
US |
2 | |
Pruritus, Injection site swelling, Dermatitis atopic, |
||||
DUPILUMAB, ALENDRONATE SODIUM, CELECOXIB, GABAPENTIN, HYDROXYCHLOROQUINE SULFATE, LEFLUNOMIDE, LISINOPRIL AND HYDROCHLOROTHIAZIDE, LISINOPRIL AND HYDROCHLOROTHIAZIDE TABLETS, SULFASALAZINE, TIZANIDINE HYDROCHLORIDE, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, VITAMIN C, ERGOCALCIFEROL, |
||||
| 1339 | 26792570 |
US |
2 | |
Dermatitis atopic, Rash, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 1340 | 26792572 |
US |
29 | 2 |
Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 1341 | 26792574 |
US |
64 | 2 |
Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 1342 | 26792616 |
US |
31 | 2 |
Blister, Skin weeping, Scab, Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 1343 | 26792650 |
US |
1 | |
Dermatitis atopic, Skin exfoliation, Dry skin, Rash, |
||||
DUPILUMAB, |
||||
| 1344 | 26792706 |
US |
73 | 2 |
Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 1345 | 26792755 |
US |
2 | |
Dermatitis atopic, Pruritus, Dry skin, Sleep disorder due to a general medical condition, |
||||
DUPILUMAB, ALBUTEROL SULFATE, FLUTICASONE FUROATE AND VILANTEROL TRIFENATATE, LISINOPRIL AND HYDROCHLOROTHIAZIDE, LISINOPRIL AND HYDROCHLOROTHIAZIDE TABLETS, METOPROLOL TARTRATE, METOROPROLOL TARTRATE, METOPROLOL, ROSUVASTATIN CALCIUM, ERGOCALCIFEROL, |
||||
| 1346 | 26792759 |
US |
91 | 2 |
Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 1347 | 26792805 |
US |
51 | 2 |
Dermatitis atopic, Product dose omission issue, |
||||
DUPILUMAB, DUPILUMAB, PROGESTERONE, FEXOFENADINE HYDROCHLORIDE, LORATADINE, LORATADINE TABLET, ESTRADIOL, ESTRADIOL GEL 0.1%, ESTRADIOL TRANSDERMAL, ESTRADIOL,, BUPROPION HYDROCHLORIDE, CETIRIZINE HYDROCHLORIDE, |
||||
| 1348 | 26792811 |
US |
39 | 2 |
Dermatitis atopic, Therapeutic response shortened, Product use in unapproved indication, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 1349 | 26792816 |
US |
17 | 1 |
Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 1350 | 26792873 |
US |
1 | |
Dermatitis atopic, Therapeutic response shortened, |
||||
DUPILUMAB, |
||||
| 1351 | 26792877 |
US |
2 | |
Rash, Eyelids pruritus, Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 1352 | 26792882 |
US |
73 | 1 |
Dermatitis atopic, Rash pruritic, Dry skin, |
||||
DUPILUMAB, |
||||
| 1353 | 26792885 |
US |
22 | 2 |
Joint swelling, Joint stiffness, Dermatitis atopic, Pruritus, Skin exfoliation, Erythema, Product dose omission issue, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 1354 | 26787205 |
US |
48 | 2 |
Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 1355 | 26787453 |
EU |
1 | 2 |
Dermatitis atopic, |
||||
| 1356 | 26787485 |
US |
1 | |
Dermatitis atopic, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 1357 | 26787497 |
US |
1 | |
Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 1358 | 26787502 |
US |
23 | 1 |
Eye inflammation, Blepharitis, Periorbital dermatitis, Dermatitis atopic, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 1359 | 26787510 |
US |
63 | 2 |
Stress, Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 1360 | 26787515 |
US |
27 | 2 |
Skin fissures, Insomnia, Tension headache, Skin exfoliation, Anxiety, Dermatitis atopic, |
||||
DUPILUMAB, ALBUTEROL SULFATE, DELGOCITINIB, FLUOXETINE HYDROCHLORIDE, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, LORAZEPAM, BREXPIPRAZOLE, TACROLIMUS, TACROLIMUS OINTMENT 0.1%, TACROLIMUS EXTENDED-RELEASE CAPSULES, ERGOCALCIFEROL, BUPROPION HYDROCHLORIDE, |
||||
| 1361 | 26787522 |
US |
7 | 2 |
Dermatitis atopic, Rash, |
||||
DUPILUMAB, |
||||
| 1362 | 26787523 |
US |
2 | |
Asthma, Dermatitis atopic, |
||||
DUPILUMAB, DUPILUMAB, ALBUTEROL SULFATE, ALBUTEROL SULFATE, DIPHENHYDRAMINE HYDROCHLORIDE, MONTELUKAST SODIUM, MONTELUKAST, TACROLIMUS, TACROLIMUS OINTMENT 0.1%, TACROLIMUS EXTENDED-RELEASE CAPSULES, FEZOLINETANT, ERGOCALCIFEROL, CETIRIZINE HYDROCHLORIDE AND PSEUDOEPHEDRINE HYDROCHLORIDE, |
||||
| 1363 | 26787540 |
US |
1 | |
Sleep disorder due to a general medical condition, Dermatitis atopic, Rash, Discomfort, Product dose omission issue, |
||||
DUPILUMAB, BUPROPION, BUPROPION, CITALOPRAM, CITALOPRAM HYDROBROMIDE, EPINEPHRINE, ADRENALINUM, CRISABOROLE, HYDROXYZINE HYDROCHLORIDE, HYDROXYZINE, HYDROXYZINE HYDROCHLORIDE ORAL, |
||||
| 1364 | 26787722 |
US |
30 | 1 |
Dry skin, Skin exfoliation, Dermatitis atopic, |
||||
DUPILUMAB, DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE, AND AMPHETAMINE SULFATE, DEXTROAMPHETAMINE SULFATE, DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE SULFATE AND AMPHETAMINE ASPARTATE, LORATADINE, LORATADINE TABLET, FISH OIL, GLYCOPYRROLATE, MUPIROCIN, MUPIROCIN CALCIUM, MONTELUKAST SODIUM, VITAMIN C, ERGOCALCIFEROL, RUXOLITINIB, |
||||
| 1365 | 26787746 |
US |
21 | 2 |
Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 1366 | 26787962 |
US |
2 | |
Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 1367 | 26788232 |
US |
10 | 1 |
Rash erythematous, Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 1368 | 26788474 |
US |
60 | 2 |
Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 1369 | 26788507 |
CN |
77 | 1 |
Atypical lymphoid hyperplasia, Dermatitis atopic, Therapeutic product effect decreased, |
||||
DUPILUMAB, METHYLPREDNISOLONE, |
||||
| 1370 | 26789189 |
US |
46 | 2 |
Dermatitis atopic, Injection site pain, Contusion, Skin mass, |
||||
DUPILUMAB, BIOTIN, FISH OIL, ERGOCALCIFEROL, |
||||
| 1371 | 26789191 |
US |
46 | 2 |
Dermatitis atopic, Therapeutic response shortened, |
||||
DUPILUMAB, |
||||
| 1372 | 26789611 |
US |
61 | 1 |
Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 1373 | 26790001 |
US |
69 | 1 |
Neoplasm malignant, Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 1374 | 26790229 |
US |
42 | 2 |
Dermatitis atopic, Loss of personal independence in daily activities, Insomnia, Mood altered, |
||||
TRALOKINUMAB-LDRM, TRALOKINUMAB-LDRM, |
||||
| 1375 | 26790350 |
US |
1 | |
Sleep disorder, Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 1376 | 26790353 |
US |
5 | 2 |
Viral infection, Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 1377 | 26790650 |
US |
2 | 1 |
Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 1378 | 26791223 |
US |
||
Dermatitis atopic, |
||||
NEMOLIZUMAB-ILTO, |
||||
| 1379 | 26791800 |
US |
4 | 2 |
Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 1380 | 26791883 |
US |
2 | |
Dermatitis atopic, Inappropriate schedule of product administration, |
||||
DUPILUMAB, |
||||
| 1381 | 26791956 |
US |
2 | |
Tendon rupture, Skin laceration, Gait disturbance, Acne, Foot deformity, Eczema, Concussion, Thermal burn, Headache, Dermatitis atopic, Eye contusion, |
||||
UPADACITINIB, UPADACITINIB, MAGNESIUM, HYDROCHLOROTHIAZIDE, HYDROCHLOROTHIAZIDE, FAMOTIDINE, ERGOCALCIFEROL, MELOXICAM, MELOXICAM, GABAPENTIN, GABAPENTIN, METHOCARBAMOL, |
||||
| 1382 | 26782302 |
US |
9 | 1 |
Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 1383 | 26782461 |
US |
1 | |
Dermatitis atopic, Therapeutic response shortened, |
||||
DUPILUMAB, |
||||
| 1384 | 26782463 |
US |
86 | 1 |
Dermatitis atopic, Product dose omission in error, |
||||
DUPILUMAB, |
||||
| 1385 | 26782672 |
US |
2 | |
Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 1386 | 26782688 |
US |
68 | 1 |
Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 1387 | 26782707 |
US |
40 | 1 |
Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 1388 | 26782712 |
US |
21 | 1 |
Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 1389 | 26782726 |
US |
2 | |
Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 1390 | 26782733 |
US |
46 | 1 |
Dermatitis atopic, Product dose omission issue, |
||||
DUPILUMAB, |
||||
| 1391 | 26782916 |
US |
2 | |
Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 1392 | 26782926 |
US |
52 | 1 |
Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 1393 | 26782936 |
US |
24 | 2 |
Dermatitis atopic, Rash, |
||||
DUPILUMAB, |
||||
| 1394 | 26783134 |
US |
36 | 2 |
Dermatitis atopic, Urticaria, Product use in unapproved indication, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 1395 | 26783138 |
US |
59 | 1 |
Knee arthroplasty, Dermatitis atopic, Hyperhidrosis, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 1396 | 26783146 |
US |
70 | 2 |
Dry skin, Skin exfoliation, Pruritus, Dermatitis atopic, Incorrect product administration duration, |
||||
DUPILUMAB, |
||||
| 1397 | 26783154 |
US |
77 | 2 |
Dermatitis atopic, Inappropriate schedule of product administration, |
||||
DUPILUMAB, |
||||
| 1398 | 26783157 |
US |
||
Dermatitis atopic, Rash, |
||||
DUPILUMAB, |
||||
| 1399 | 26783162 |
US |
35 | 2 |
Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 1400 | 26783397 |
US |
79 | 2 |
Dermatitis atopic, |
||||
DUPILUMAB, |
||||
disclaimer
Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.
terms
license
last_updated
2026-07-30